Michael S. Khodadoust, Ph.D.
Affiliations: | 2010 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Immunology, OncologyGoogle:
"Michael Khodadoust"Parents
Sign in to add mentor| David M. Markovitz | grad student | 2010 | University of Michigan | |
| (Sub-nuclear localization and tumorigenic function of the oncoprotein DEK.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sworder BJ, Kurtz DM, Alig SK, et al. (2022) Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas. Cancer Cell |
| Weng WK, Arai S, Rezvani A, et al. (2020) Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma. Blood Advances. 4: 4474-4482 |
| Frank MJ, Khodadoust MS, Czerwinski DK, et al. (2020) Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial. The Journal of Experimental Medicine. 217 |
| Hoffmann JC, Atwater SK, Hong E, et al. (2020) A Long-Term Study of Persistent Sézary Syndrome: Evidence for Antigen Shift by Multiparameter Flow Cytometry and Its Significance in Overall Survival. The American Journal of Dermatopathology. 42: 389-396 |
| Schürch CM, Phillips DJ, Gutierrez BR, et al. (2020) Abstract 6669: Cellular neighborhoods predict pembrolizumab response in cutaneous T cell lymphoma Immunology. 80: 6669-6669 |
| Bagot M, Porcu P, Marie-Cardine A, et al. (2019) IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial. The Lancet. Oncology |
| Newman AM, Steen CB, Liu CL, et al. (2019) Determining cell type abundance and expression from bulk tissues with digital cytometry. Nature Biotechnology |
| Obeid JP, Gutkin PM, Lewis J, et al. (2019) Volumetric modulated arc therapy and 3-dimensional printed bolus in the treatment of refractory primary cutaneous gamma delta lymphoma of the bilateral legs. Practical Radiation Oncology |
| Wagar LE, Sworder B, Khodadoust MS, et al. (2019) Follicular Lymphoma Organoids for Investigating the Tumor Microenvironment Blood. 134: 2799-2799 |
| Shree T, Khodadoust MS, Czerwinski DK, et al. (2019) A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma Blood. 134: 2825-2825 |